Article: RHONE-POULENC RORER REPORTS THIRD QUARTER RESULTS AND ANNOUNCES CURTAILMENT OF YEAR-END TRADE INCENTIVES

 
COLLEGEVILLE, Pa., and PARIS, Oct. 21 /PRNewswire/ -- Rhone-Poulenc Rorer (NYSE: RPR) today announced third quarter 1993 earnings per share of $.51 including an expected pretax charge of $27 million ($.13 per share) for acquired research and development costs stemming from the previously announced transaction with Applied Immune Sciences, Inc., which closed this quarter. 
Results in the quarter also included gains from the sale of certain product rights of $.02 per share ($.04 per share in 1992).  Earnings per share in the third quarter 1992 was $.66.  Excluding the above transactions, earnings per share for both periods would have been $.62 as expected. 
The stronger ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!